Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Articolo

Data di Pubblicazione:

2014

Citazione:

Phillips, A., Cambiano, V., Nakagawa, F., Magubu, T., Miners, A., Ford, D., Pillay, D., De Luca, A., Lundgren, J., Revill, P., Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings, <>, 2014; 9 (10): e109148-e109148. [doi:10.1371/journal.pone.0109148] [http://hdl.handle.net/10807/63937]

Abstract:

To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified.

Tipologia CRIS:

Articolo in rivista, Nota a sentenza

Keywords:

therapy; cost; HIV

Elenco autori: